The effects of JAK inhibitor therapy upon novel markers of thrombosis In myeloproliferative neoplasms

Ítems similars

• Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms
  per: Naoimh Herlihy, et al.
  Publicat: (2019-04-01)
• The effects of JAK inhibitor therapy upon novel markers of thrombosis In myeloproliferative neoplasms
  per: Clodagh Keohane, et al.
  Publicat: (2015-09-01)
• Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm
  per: Pingnan Xiao, et al.
  Publicat: (2018-03-01)
• The Hematopoietic Niche in Myeloproliferative Neoplasms
  per: Annette H. Schmitt-Graeff, et al.
  Publicat: (2015-01-01)
• “ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
  per: Hélène F.E. Gleitz, et al.
  Publicat: (2022-08-01)